showed that silencing of STAT3 can enhance the antitumor activity of HSV-TK delivered by an adenoviral vehicle by inhibiting cell proliferation and eliciting an anticancer immune response in tumor-bearing mice (Ahn et al., 2012). This evidence concerns the gene STAT3 and neoplasm.